Limited data are available concerning the outcome of patients with aty
pical and malignant meningiomas. We therefore analyzed the outcome of
seventeen patients with meningiomas (9 atypical; 8 malignant) at Thoma
s Jefferson University Hospital between 1973 and 1996. Strict adherenc
e to the 1993 WHO criteria for the typing of CNS tumors was maintained
. The median potential follow-up period for all patients was 87 months
. The age at diagnosis ranged from 22 to 72 (mean 51.8 years). There w
ere 5 males and 12 females. The mean tumor diameter was 4.45 cm. Of th
e 16 cases where the extent of surgical resection was known, 4 were pa
rtial and 12 were complete resections. Six patients (35%) had dural or
cortical invasion by tumor. Fifteen patients received postoperative m
egavoltage photon irradiation (mean 61 Gy). One of these fifteen pts.
received an additional 20 Gy with Au-198 implantation and 1 received p
ost-radiation chemotherapy for recurrent disease. The overall survival
rate for all patients at 5 and 10 years were 87% and 58% respectively
. The 5- and 10-year survival rates for atypical meningiomas were 87%
and 58%; for malignant meningiomas the survival rates were 60% and 60%
respectively. Five patients (30%) have died. Three of these 5 patient
s initially received less than 54 Gy to the tumor bed and have died of
recurrent disease. Local disease progression was documented in 11 pat
ients (65%) after surgery and in 3 patients (18%) after radiation. The
re was an improvement in performance status in 3 (18%) paients with a
decline and no change seen in 1 (6%) and 13 (77%) respectively after r
eceiving radiation. There appeared to be no difference in survival in
patients as a function of dural or cortical invasion. Long term surviv
al is possible for patients with atypical and malignant meningiomas tr
eated with surgery and post-operative radiation. We are unable to dist
inguish a difference in outcome between these two pathological entitie
s. Dural and cortical invasion were not associated with a decrease in
survival. In addition, improved tumor control and survival may be asso
ciated with increased radiation dose.